Gleneagles Hospital Hong Kong marked the beginning of its local antimicrobial resistance (AMR) programme with a pledge to promote the responsible use of antibiotics and help raise public awareness of AMR.
Led by its CEO Dr Kenneth Tsang, the hospital departments showed their support by pledging to use antibiotics responsibly.
As part of IHH’s sustainability commitment to Care for Public, all IHH hospitals will implement antimicrobial resistance interventions in line with CDC, WHO and national guidelines by 2025.
Related Stories
Fortis and Agilus Accelerate Precision Cancer Diagnostics
Fortis Memorial Research Institute, Gurugram, in collaboration with Agilus Diagnostics, the diagnostics arm of Fortis Healthcare, has launched its second Ion Torrent Genexus system, marking a significant step forward in enhancing precision cancer diagnostics in India.
Advancing Patient-centred Care with Digital Transformation
IHH Healthcare has partnered with Virtusa Corporation, a leading global provider of digital strategy and IT services, to support our digital transformation initiative across our global network.
IHH Singapore Honoured for Corporate Giving Excellence
Gleneagles JPMC Strengthens Cross-Border Healthcare Collaboration
From Patient to Pillar of Support: A Cancer Survivor’s Journey at Acibadem Kent Hospital
When Neslihan Ergin was diagnosed with breast cancer in early 2020, she never imagined that the hospital where she received treatment would one day become her workplace and her new purpose.
Pantai Hospital Ipoh Achieves Surgical Milestone with First Minimally Invasive Thymectomy
With the successful completion of its first minimally invasive surgical procedure to remove the thymus gland, Pantai Hospital Ipoh has taken a major step forward in patient-centred care.
